Post‐licensure safety surveillance for human papillomavirus‐16/18‐AS04‐adjuvanted vaccine: more than 4 years of experience

The environment and disease: association or causation?

2015 • 7,281 citations

Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis

2001 • 6,888 citations

The Environment and Disease: Association or Causation?

1965 • 6,436 citations

The Prevalence of Congenital Anomalies in Europe

2010 • 601 citations

Guillain–Barré syndrome and Fisher syndrome: Case definitions and guidelines for collection, analysis, and presentation of immunization safety data

2010 • 566 citations

Guidelines for case classification for the national birth defects prevention study

2003 • 545 citations

Limitations and strengths of spontaneous reports data

1998 • 222 citations

The epidemiology and treatment of Bell’s palsy in the UK

2002 • 219 citations

Estimated pregnancy rates by outcome for the United States, 1990-2004.

2008 • 208 citations

Attitude survey of adverse drug-reaction reporting by health care professionals across the European Union

1997 • 197 citations

Encephalitis, myelitis, and acute disseminated encephalomyelitis (ADEM): Case definitions and guidelines for collection, analysis, and presentation of immunization safety data

2007 • 181 citations

Analysis of adverse events of potential autoimmune aetiology in a large integrated safety database of AS04 adjuvanted vaccines

2008 • 149 citations

Safety of Human Papillomavirus Vaccines: A Review

2013 • 144 citations

Estimates of the Annual Number of Clinically Recognized Pregnancies in the United States, 1981-1991

1999 • 138 citations

Contents & welcoming letter

2007 • 112 citations

Human Papilloma Virus Immunization in Adolescent and Young Adults

2007 • 107 citations

The current state of introduction of human papillomavirus vaccination into national immunisation schedules in Europe: first results of the VENICE2 2010 survey

2010 • 103 citations

No Association Between Immunization and Guillain-Barré Syndrome in the United Kingdom, 1992 to 2000

2006 • 103 citations

Risk and Benefit of Drug Use During Pregnancy

2005 • 97 citations

Pooled analysis of large and long‐term safety data from the human papillomavirus‐16/18‐AS04‐adjuvanted vaccine clinical trial programme

2014 • 87 citations

New approaches to drug safety: a pharmacovigilance tool kit

2009 • 79 citations

Optimal approaches to data collection and analysis of potential immune mediated disorders in clinical trials of new vaccines

2013 • 71 citations

Medical genetics: 1. Clinical teratology in the age of genomics.

2002 • 64 citations

The identification of pregnancies within the general practice research database

2009 • 63 citations

Incidence and lifetime prevalence of Bell's palsy in two Sicilian municipalities

1996 • 38 citations

Design or Accident? The Natural History of Teenage Pregnancy

2001 • 28 citations

Safety and tolerability of bivalent HPV vaccine: An Italian post-licensure study

2011 • 17 citations

Benefit-Risk Balance for Marketed Drugs: Evaluating Safety Signals, Report of CIOMS Working Group IV

1999 • 9 citations

Adverse events following vaccination against human papillomavirus : Results of the 2010 campaign in the Netherlands

2011 • 4 citations

Impact of Geographic and Cross-Cultural Differences on Spontaneous Adverse Events Reporting

1999 • 2 citations